Chemotherapy
Microbiology
A 13-Year Study of Antimicrobial Susceptibility of Common Gram-Negative Bacteria Isolated from the Bloodstream in a Teaching HospitalLing T.K.W. · Ling T.K.W. · Liu E.Y.M. · Liu E.Y.M. · Cheng A.F.B. · Cheng A.F.B.Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, SAR, PR China
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: December 13, 2000
Issue release date: January – February
Number of Print Pages: 10
Number of Figures: 3
Number of Tables: 2
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Abstract
The choice of antimicrobial therapy for the treatment of bacteremia is often empirical and based on the knowledge of susceptibility profiles of the most common bacteria. We analyzed blood culture isolates from a teaching hospital for 13 years prospectively. This study examined the susceptibility profiles of 6,616 gram-negative bacteria. Escherichia coli ranked among the commonest bacteria, representing 43.6% (2,890) of all gram-negative isolates. Klebsiella sp. ranked second, 17.7% (1,171) and 16.7% were resistant to ceftazidime in 1997. There was a trend towards an increase in resistance to fluoroquinolones in the common gram-negative bacteria. Imipenem was the most active agent against gram-negative bacteria. The results of the susceptibility of gram-negative bacteria causing bacteremia provide valuable information for implementing the appropriate chemotherapy for bacteremia.
© 1999 S. Karger AG, Basel
Related Articles:
References
- Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD: The benefit of appropriate empirical antibiotic treatment patients with bloodstream infection. J Intern Med 1998;244:379–386.
- Rintala E, Kairisto V, Eerola E, Nikoskelainen J, Lehtonen OP: Antimicrobial therapy of septicemic patients in intensive care units before and after blood culture reporting. Scand J Infect Dis 1991;23:341–346.
- Krcmery V Jr, Spanik S, Krupova I, Trupl J, Kunova A, Smid M, Pichnova E: Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: A case controlled study. J Chemother 1998;10:320–325.
- Yinnon AM, Schlesinger Y, Gabbay D, Rudensky B: Analysis of 5 years of bacteraemias: Importance of stratification of microbial susceptibilities by source of patients. J Infect 1997;35:17–23.
-
Cowan ST: Cowan and Steel’s Manual for the Identification of Medical Bacteria, ed 3. Cambridge, Cambridge University Press, 1993.
-
Murray PR, Barron EJ, Pfaller MA, Tenover FC, Yolken RH: Manual of Clinical Microbiology, ed 6. Washington, American Society for Microbiology, 1995.
-
BSAC standardized disc sensitivity testing method. Newslett Br Soc Antimicrob Chemother 1998.
-
Report of the working party of the British Society for Antimicrob Chemother: A guide to sensitivity testing. J Antimicrob Chemother 1991;27(suppl D):1–50.
- Chamberland S, L’Ecuyer J, Lessard C, Bernier M, Provencher P, Bergeron MG: Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada: The Canadian Study Group. Clin Infect Dis 1992;15:615–628.
- Escande MC, Herbrecht R: Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. Support Care Cancer 1998;6:273–280.
- Fredlund H, Bjoreman M, Kjellander J, Sjoberg L, Bjorne L, Ohlin AL: A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with hematological diseases at a major Swedish hospital. Scand J Infect Dis 1990;22:381–391.
-
Phillips I, King A, William RG, Eykyn SJ: The antibiotic sensitivity of bacteria isolated from the blood of patients in St. Thomas’ Hospital, 1969–1988. J Antimicrob Chemother 1990;25(suppl C):59–80.
- Threlfall EJ, Cheasty T, Graham A, Rowe B: Antibiotic resistance in Escherichia coli isolated from blood and cerebrospinal fluid: A 6-year study of isolates from patients in England and Wales. Int J Antimicrob Agents 1997;9:201–205.
- Walder M, Karlsson E, Nilsson B: Sensitivity of 880 blood culture isolates to 24 antibiotics. Scand J Infect Dis 1994;26:67–75.
-
French GL, Cheng AFB, Duthie R, Cockram CS: Septicaemia in Hong Kong. J Antimicrob Chemother 1990;25(suppl C):115–125.
-
Ling TKW: Septicemia; in Moellering RC Jr (ed): Treatment of Severe Gram-Positive Infections: The Role of Quinupristin/Dalfopristin. Chicago, PharmaLibri, 1998, pp 49–59.
-
Lyon DJ, Scheel O, Adeyemi-Doro FAB, Ling TKW, Cheng AFB, Norrby SR: Antimicrobial susceptibility and extended-spectrum β-lactamases of Hong Kong isolates of Enterobacteriaceae. Scand J Infect Dis 1996;(suppl 101):17–20.
- Bergeron MG, Bernier M: Bactericidal activity of cefpirome (HR 810) against 513 gram-negative bacteria isolated from blood of septicemic patients. Infection 1994;22:299–305.
-
Ling JM, Ng TKC, Cheng AF, Norrby SR: Susceptibilities to 23 antimicrobial agents and β-lactamase production of blood culture isolates of Acinetobacter sp. in Hong Kong. Scand J Infect Dis 1996;(suppl 101):21–25.
-
Ling JM, Cheng AF: Antimicrobial resistance of clinical isolates from 1987 to 1993 in Hong Kong. Hong Kong Med J 1995;1:212–217.
-
Ng TKC, Ling JM, Cheng AF, Norrby SR: A retrospective study of clinical characteristics of acinetobacter bacteremia. Scand J Infect Dis 1996(suppl 101):26–32.
Article / Publication Details
Published online: December 13, 2000
Issue release date: January – February
Number of Print Pages: 10
Number of Figures: 3
Number of Tables: 2
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
